Key metrics and charts across all fundamental categories.
Stock price and market valuation
MEDP trades at $503.43, a 65.2% increase year-over-year. Market capitalization stands at $14.32B, up 54.7% from the prior year. Track MEDP price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$2.68B in TTM revenue grew 24.2% YoY, reaching $706.60M last quarter. TTM EBITDA of $591.01M on operating income of $141.50M shows growth is flowing through. Net income of $460.40M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
Price multiples and return ratios
At 31.1x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 5.3x and P/B of 23.9x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 20.0% is down 0.3% YoY — costs are rising relative to revenue. Net margin at 17.5%. ROE of 76.9% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $144.97M on $151.79M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $652.68M provide financial flexibility. Shares outstanding declined 6.4% YoY — buybacks are returning capital to shareholders.
